AstraZeneca submitted outdated numbers in its latest vaccine study. They’ve republished their work, but that slip-up came at a cost.
AstraZeneca Less Effective in Revised Study
Sign up for NTD Daily
What you need to know, summarized in one email.
Stay informed with accurate news you can trust.
Stay informed with accurate news you can trust.
Success! You are now subscribed.
By registering for the newsletter, you agree to the Privacy Policy.